209 related articles for article (PubMed ID: 35262376)
1. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
[No Abstract] [Full Text] [Related]
2. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with 60-day adherence to "safer supply" opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency.
Selfridge M; Card K; Kandler T; Flanagan E; Lerhe E; Heaslip A; Nguyen A; Moher M; Pauly B; Urbanoski K; Fraser C
Int J Drug Policy; 2022 Jul; 105():103709. PubMed ID: 35525052
[TBL] [Abstract][Full Text] [Related]
4. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
[TBL] [Abstract][Full Text] [Related]
5. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
6. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
[TBL] [Abstract][Full Text] [Related]
7. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
[TBL] [Abstract][Full Text] [Related]
8. British Columbia's Safer Opioid Supply Policy and Opioid Outcomes.
Nguyen HV; Mital S; Bugden S; McGinty EE
JAMA Intern Med; 2024 Mar; 184(3):256-264. PubMed ID: 38227344
[TBL] [Abstract][Full Text] [Related]
9. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
[No Abstract] [Full Text] [Related]
10. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
11. Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
Slaunwhite A; Min JE; Palis H; Urbanoski K; Pauly B; Barker B; Crabtree A; Bach P; Krebs E; Dale L; Meilleur L; Nosyk B
BMJ; 2024 Jan; 384():e076336. PubMed ID: 38199614
[TBL] [Abstract][Full Text] [Related]
12. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
13. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
[TBL] [Abstract][Full Text] [Related]
14. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
[TBL] [Abstract][Full Text] [Related]
15. Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia.
Kamal A; Ferguson M; Xavier JC; Liu L; Graham B; Lock K; Buxton JA
Subst Abuse Treat Prev Policy; 2023 May; 18(1):27. PubMed ID: 37194018
[TBL] [Abstract][Full Text] [Related]
16. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
[TBL] [Abstract][Full Text] [Related]
17. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts.
Bowles J; Mansoor M; Werb D; Kerr T; Bardwell G
J Subst Use Addict Treat; 2024 Feb; 157():209185. PubMed ID: 37865289
[TBL] [Abstract][Full Text] [Related]
18. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
[TBL] [Abstract][Full Text] [Related]
19. Opioid prescribing practice standard in British Columbia, Canada: Rationale, controversies, and directions.
Lim J; McCracken RK; Panagiotoglou D
Int J Drug Policy; 2021 Nov; 97():103363. PubMed ID: 34314955
[TBL] [Abstract][Full Text] [Related]
20. A qualitative study on perceptions and experiences of overdose among people who smoke drugs in Vancouver, British Columbia.
Ivsins A; Bonn M; McNeil R; Boyd J; Kerr T
Drug Alcohol Depend; 2024 May; 258():111275. PubMed ID: 38581922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
